Árangur míturlokuviðgerða á Íslandi 2001-2012

Efst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn Vægur míturlokuleki er meðhöndlaður með lyfjum en við alvarlegan leka þarf að beita skurðaðgerð, en viðgerðir með hjartaþræðingartækni eru í örri þróun. Míturlokuviðgerðir hafa rutt sér til rúms í stað lokuskipta....

Full description

Bibliographic Details
Main Authors: Jóhanna Fríða Guðmundsdóttir, Sigurður Ragnarsson, Arnar Geirsson, Ragnar Danielsen, Tómas Guðbjartsson
Other Authors: Landspítali Hringbraut, Læknadeild Háskóli Íslands, Háskólasjúkrahúsið Skáni í Lundi Svíþjóð
Format: Article in Journal/Newspaper
Language:Icelandic
Published: Læknafélag Íslands, Læknafélag Reykjavi­kur 2014
Subjects:
Online Access:http://hdl.handle.net/2336/336501
id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/336501
record_format openpolar
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/336501 2023-05-15T16:46:50+02:00 Árangur míturlokuviðgerða á Íslandi 2001-2012 Surgical outcome of mitral valve repair in Iceland 2001-2012. Jóhanna Fríða Guðmundsdóttir Sigurður Ragnarsson Arnar Geirsson Ragnar Danielsen Tómas Guðbjartsson Landspítali Hringbraut, Læknadeild Háskóli Íslands, Háskólasjúkrahúsið Skáni í Lundi Svíþjóð 2014 http://hdl.handle.net/2336/336501 ICE is ice Læknafélag Íslands, Læknafélag Reykjavi­kur http://www.laeknabladid.is Læknablaðið 2014, 100 (11):579-584 0023-7213 25413887 http://hdl.handle.net/2336/336501 Læknablaðið openAccess Open Access Hjartaaðgerðir Female Heart Valve Prosthesis Heart Valve ProsthesisImplantation*/adverse effects Treatment Outcome Reoperation Time Factors Heart Valve ProsthesisImplantation*/instrumentation Risk Factors Risk Assessment Prosthesis Design Heart Valve Prosthesis Implantation*/mortality Retrospective Studies Humans Iceland/epidemiology Kaplan-Meier Estimate Male Middle Aged Mitral Valve/surgery* Mitral Valve Insufficiency/mortality Mitral Valve Insufficiency/surgery* Mitral Valve Stenosis/mortality Mitral Valve Stenosis/surgery* Postoperative Complications/etiology Postoperative Complications/mortality PostoperativComplications/surgery Article 2014 ftlandspitaliuni 2022-05-29T08:22:00Z Efst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn Vægur míturlokuleki er meðhöndlaður með lyfjum en við alvarlegan leka þarf að beita skurðaðgerð, en viðgerðir með hjartaþræðingartækni eru í örri þróun. Míturlokuviðgerðir hafa rutt sér til rúms í stað lokuskipta. Lokublöðin eru lagfærð og komið fyrir míturlokuhring. Rannsóknir hafa sýnt að snemmkominn árangur og langtímalifun eru umtalsvert betri eftir viðgerð en lokuskipti. --- Objectives: To review, for the first time, the outcome of mitral valve repair operations in Iceland. Material and methods: A retrospective study of all mitral valve repair patients (average age 64 yrs, 74% males) operated in Iceland 2001-2012. All 125 patients had mitral regurgitation; either due to degenerative disease (56%) or functional regurgitation (44%). Survival was estimated using the Kaplan-Meier method. The median follow-up time was 3.9 years Results: The number repair-procedures increased from 39 during the first half of the study period to 86 during the latter period. The mean EuroSCORE was 12.9% and 2/3 of the patients were in NYHA class III/IV. Half of them had severe mitral regurgitation, 12% had a recent myocardial infarction, and 10% a history of previous cardiac surgery. A ring annuloplasty was performed in 98% of cases, a posterior leaflet resection was done in 51 patients (41%), 28 received artificial chordae (Goretex®) and 7 an Alfieri-stitch. Concomitant cardiac surgery was performed in 83% of cases, where coronary artery bypass (53%), Maze-procedure (31%) or aortic valve replacement (19%) were most common. Major complications occurred in 56% of the cases and minor complications were noted in 71% of cases. Two patients later required mitral valve replacement. Eight patients died within 30 days (6%) and 5-year overall survival was 79%; or 84% and 74% for the degenerative and functional groups, respectively. Conclusions: The number of mitral valve repairs in Iceland increased significantly over the study period. Complications ... Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Meier ENVELOPE(-45.900,-45.900,-60.633,-60.633) Leka ENVELOPE(11.709,11.709,65.089,65.089) Smella ENVELOPE(29.443,29.443,69.896,69.896)
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language Icelandic
topic Hjartaaðgerðir
Female
Heart Valve Prosthesis
Heart Valve ProsthesisImplantation*/adverse effects
Treatment Outcome
Reoperation
Time Factors
Heart Valve ProsthesisImplantation*/instrumentation
Risk Factors
Risk Assessment
Prosthesis Design
Heart Valve Prosthesis Implantation*/mortality
Retrospective Studies
Humans
Iceland/epidemiology
Kaplan-Meier Estimate
Male
Middle Aged
Mitral Valve/surgery*
Mitral Valve Insufficiency/mortality
Mitral Valve Insufficiency/surgery*
Mitral Valve Stenosis/mortality
Mitral Valve Stenosis/surgery*
Postoperative Complications/etiology
Postoperative Complications/mortality
PostoperativComplications/surgery
spellingShingle Hjartaaðgerðir
Female
Heart Valve Prosthesis
Heart Valve ProsthesisImplantation*/adverse effects
Treatment Outcome
Reoperation
Time Factors
Heart Valve ProsthesisImplantation*/instrumentation
Risk Factors
Risk Assessment
Prosthesis Design
Heart Valve Prosthesis Implantation*/mortality
Retrospective Studies
Humans
Iceland/epidemiology
Kaplan-Meier Estimate
Male
Middle Aged
Mitral Valve/surgery*
Mitral Valve Insufficiency/mortality
Mitral Valve Insufficiency/surgery*
Mitral Valve Stenosis/mortality
Mitral Valve Stenosis/surgery*
Postoperative Complications/etiology
Postoperative Complications/mortality
PostoperativComplications/surgery
Jóhanna Fríða Guðmundsdóttir
Sigurður Ragnarsson
Arnar Geirsson
Ragnar Danielsen
Tómas Guðbjartsson
Árangur míturlokuviðgerða á Íslandi 2001-2012
topic_facet Hjartaaðgerðir
Female
Heart Valve Prosthesis
Heart Valve ProsthesisImplantation*/adverse effects
Treatment Outcome
Reoperation
Time Factors
Heart Valve ProsthesisImplantation*/instrumentation
Risk Factors
Risk Assessment
Prosthesis Design
Heart Valve Prosthesis Implantation*/mortality
Retrospective Studies
Humans
Iceland/epidemiology
Kaplan-Meier Estimate
Male
Middle Aged
Mitral Valve/surgery*
Mitral Valve Insufficiency/mortality
Mitral Valve Insufficiency/surgery*
Mitral Valve Stenosis/mortality
Mitral Valve Stenosis/surgery*
Postoperative Complications/etiology
Postoperative Complications/mortality
PostoperativComplications/surgery
description Efst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn Vægur míturlokuleki er meðhöndlaður með lyfjum en við alvarlegan leka þarf að beita skurðaðgerð, en viðgerðir með hjartaþræðingartækni eru í örri þróun. Míturlokuviðgerðir hafa rutt sér til rúms í stað lokuskipta. Lokublöðin eru lagfærð og komið fyrir míturlokuhring. Rannsóknir hafa sýnt að snemmkominn árangur og langtímalifun eru umtalsvert betri eftir viðgerð en lokuskipti. --- Objectives: To review, for the first time, the outcome of mitral valve repair operations in Iceland. Material and methods: A retrospective study of all mitral valve repair patients (average age 64 yrs, 74% males) operated in Iceland 2001-2012. All 125 patients had mitral regurgitation; either due to degenerative disease (56%) or functional regurgitation (44%). Survival was estimated using the Kaplan-Meier method. The median follow-up time was 3.9 years Results: The number repair-procedures increased from 39 during the first half of the study period to 86 during the latter period. The mean EuroSCORE was 12.9% and 2/3 of the patients were in NYHA class III/IV. Half of them had severe mitral regurgitation, 12% had a recent myocardial infarction, and 10% a history of previous cardiac surgery. A ring annuloplasty was performed in 98% of cases, a posterior leaflet resection was done in 51 patients (41%), 28 received artificial chordae (Goretex®) and 7 an Alfieri-stitch. Concomitant cardiac surgery was performed in 83% of cases, where coronary artery bypass (53%), Maze-procedure (31%) or aortic valve replacement (19%) were most common. Major complications occurred in 56% of the cases and minor complications were noted in 71% of cases. Two patients later required mitral valve replacement. Eight patients died within 30 days (6%) and 5-year overall survival was 79%; or 84% and 74% for the degenerative and functional groups, respectively. Conclusions: The number of mitral valve repairs in Iceland increased significantly over the study period. Complications ...
author2 Landspítali Hringbraut, Læknadeild Háskóli Íslands, Háskólasjúkrahúsið Skáni í Lundi Svíþjóð
format Article in Journal/Newspaper
author Jóhanna Fríða Guðmundsdóttir
Sigurður Ragnarsson
Arnar Geirsson
Ragnar Danielsen
Tómas Guðbjartsson
author_facet Jóhanna Fríða Guðmundsdóttir
Sigurður Ragnarsson
Arnar Geirsson
Ragnar Danielsen
Tómas Guðbjartsson
author_sort Jóhanna Fríða Guðmundsdóttir
title Árangur míturlokuviðgerða á Íslandi 2001-2012
title_short Árangur míturlokuviðgerða á Íslandi 2001-2012
title_full Árangur míturlokuviðgerða á Íslandi 2001-2012
title_fullStr Árangur míturlokuviðgerða á Íslandi 2001-2012
title_full_unstemmed Árangur míturlokuviðgerða á Íslandi 2001-2012
title_sort árangur míturlokuviðgerða á íslandi 2001-2012
publisher Læknafélag Íslands, Læknafélag Reykjavi­kur
publishDate 2014
url http://hdl.handle.net/2336/336501
long_lat ENVELOPE(-45.900,-45.900,-60.633,-60.633)
ENVELOPE(11.709,11.709,65.089,65.089)
ENVELOPE(29.443,29.443,69.896,69.896)
geographic Meier
Leka
Smella
geographic_facet Meier
Leka
Smella
genre Iceland
genre_facet Iceland
op_relation http://www.laeknabladid.is
Læknablaðið 2014, 100 (11):579-584
0023-7213
25413887
http://hdl.handle.net/2336/336501
Læknablaðið
op_rights openAccess
Open Access
_version_ 1766036929659273216